Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 2195K) PPT slides of all figures Supplemental Material Index Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JCB Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Cullen, S. P. Articles by Martin, S. J. Search for Related Content PubMed PubMed Citation Articles by Cullen, S. P. Articles by Martin, S. J. Social Bookmarking                            What's this?

Human and murine granzyme B exhibit divergent substrate preferences

Molecular Cell Biology Laboratory, Department of Genetics, The Smurfit Institute, Trinity College, Dublin 2, Ireland

Correspondence to Seamus J. Martin: martinsj{at}tcd.ie

The cytotoxic lymphocyte protease granzyme B (GzmB) can promote apoptosis through direct processing and activation of members of the caspase family. GzmB can also cleave the BH3-only protein, BID, to promote caspase-independent mitochondrial permeabilization. Although human and mouse forms of GzmB exhibit extensive homology, these proteases diverge at residues predicted to influence substrate binding. We show that human and mouse GzmB exhibit radical differences in their ability to cleave BID, as well as several other key substrates, such as ICAD and caspase-8. Moreover, pharmacological inhibition of caspases clonogenically rescued human and mouse target cells from apoptosis initiated by mouse GzmB, but failed to do so in response to human GzmB. These data demonstrate that human and murine GzmB are distinct enzymes with different substrate preferences. Our observations also illustrate how subtle differences in enzyme structure can radically affect substrate selection.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Hoves, S., Trapani, J. A., Voskoboinik, I. (2010). The battlefield of perforin/granzyme cell death pathways. J. Leukoc. Biol. 87: 237-243 [Abstract] [Full Text]  
• Cullen, S. P., Afonina, I. S., Donadini, R., Luthi, A. U., Medema, J. P., Bird, P. I., Martin, S. J. (2009). Nucleophosmin Is Cleaved and Inactivated by the Cytotoxic Granule Protease Granzyme M during Natural Killer Cell-mediated Killing. J. Biol. Chem. 284: 5137-5147 [Abstract] [Full Text]  
• Van Damme, P., Maurer-Stroh, S., Plasman, K., Van Durme, J., Colaert, N., Timmerman, E., De Bock, P.-J., Goethals, M., Rousseau, F., Schymkowitz, J., Vandekerckhove, J., Gevaert, K. (2009). Analysis of Protein Processing by N-terminal Proteomics Reveals Novel Species-specific Substrate Determinants of Granzyme B Orthologs. Mol. Cell. Proteomics 8: 258-272 [Abstract] [Full Text]  
• Jiang, X., Patterson, N. M., Ling, Y., Xie, J., Helferich, W. G., Shapiro, D. J. (2008). Low Concentrations of the Soy Phytoestrogen Genistein Induce Proteinase Inhibitor 9 and Block Killing of Breast Cancer Cells by Immune Cells. Endocrinology 149: 5366-5373 [Abstract] [Full Text]  
• Goping, I. S., Sawchuk, T., Rieger, A., Shostak, I., Bleackley, R. C. (2008). Cytotoxic T lymphocytes overcome Bcl-2 inhibition: target cells contribute to their own demise. Blood 111: 2142-2151 [Abstract] [Full Text]  
• Scott, G. B., Meade, J. L., Cook, G. P. (2008). Profiling killers; unravelling the pathways of human natural killer cell function. Brief Funct Genomic Proteomic 0: elm037v1-elm037 [Abstract] [Full Text]  
• Cullen, S. P., Adrain, C., Luthi, A. U., Duriez, P. J., Martin, S. J. (2007). Human and murine granzyme B exhibit divergent substrate preferences. JEM 204: i4-i4 [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents